JJ
John Patrick Shannon Jr (See Remarks) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Xeris Biopharma Holdings, Inc. (XERS). The largest single filing was $176K of XERS (24,907 sh × $7.08, as filed), executed Jan 5. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$176K
shares × price, as filed
Last traded
Jan 5
Filed Jan 6
Median ADV $16.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $350K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
XERS
Xeris Biopharma Holdings, Inc.
XERS · 0 buys · 2 sells
2 filings
Recent filings
XERSSALE
Xeris Biopharma Holdings, Inc.
View filing →
$176K24,907 sh × $7.08
Exec Jan 5
Filed Jan 6 · 5:30 PM ET XERSSALE Xeris Biopharma Holdings, Inc. View filing → $173K
23,242 sh × $7.46
Exec Nov 13 2025
Filed Nov 17 2025 · 5:30 PM ET